EcoDrugPlus

Thyroid Hormone Receptor Beta

Ensembl ID : ENSSTOG00000005197
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSSTOG00000015264
Gene Symbol: TRHR
3 Cross references
266 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSSTOG00000027535
Gene Symbol: TLR2
3 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSSTOG00000021892
Gene Symbol: TLR4
3 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSSTOG00000026389
Gene Symbol: TLR7
2 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSTOG00000006087
Gene Symbol: TLR8
3 Cross references
200 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSSTOG00000021472
Gene Symbol: TLR9
4 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSTOG00000031624
Gene Symbol: TAAR1
4 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSSTOG00000013570
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSSTOG00000005024
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSSTOG00000014749
Gene Symbol: TRPM8
4 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSSTOG00000002029
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).